Efficacy of vedolizumab in patients with Crohn's disease: A prospective observational multicenter study
Latest Information Update: 25 Nov 2022
At a glance
- Drugs Vedolizumab (Primary)
- Indications Crohn's disease; Ulcerative colitis
- Focus Therapeutic Use
- Acronyms Sveah Cd Study; SVEAH Study
- 11 Oct 2022 Results (n=114) of extension study presented at the 30th United European Gastroenterology Week
- 10 Jul 2020 New trial record
- 19 May 2020 Results published in Gasteroenterology in conjunction with Digestive Disease Week 2020.